Soluble complement receptor type 1 protects rats from lethal shock induced by anti-Crry antibody following lipopolysaccharide priming

International Archives of Allergy and Immunology

Volumn 127, Issue 1, 2002, Pages 55-62

  Mizuno, Masashi ^a   Nishikawa, Kazuhiro ^a   Okada, Noriko ^b   Matsuo, Seiichi ^a   Okada, Hidechika ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Complement; Endotoxin shock; Inflammation; Lipopolysaccharide; Soluble complement receptor type 1

Indexed keywords

COBROTOXIN; COMPLEMENT COMPONENT C3B RECEPTOR; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMPLEMENT ACTIVATION; CONTROLLED STUDY; EVALUATION; LETHALITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; SEPTIC SHOCK;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; COMPLEMENT ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; RECOMBINANT PROTEINS; SHOCK, SEPTIC; SOLUBILITY;

EID: 0036121043     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048169     Document Type: Article

References (33)

1. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
2. A controlled trial of HA-1A in a canine model of gram-negative septic shock
3. Characterization of complement anaphylatoxins and their biological responses
4. Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies
5. Protective effects of C5a blockade in sepsis
6. Inhibition of a membrane complement regulatory protein by a monoclonal antibody induces acute lethal shock in rats primed with lipopolysaccharide
7. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury
8. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat
9. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
10. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species
11. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rat by blocking of CD59
12. Complement inhibitor of rat cell membrane resembling mouse Crry/p65
13. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats
14. Molecular cloning of the rat complement regulatory protein, 5I2 antigen
15. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis
16. The effects of functional suppression of a membrane-bound complement regulatory protein, CD59, in the synovial tissue in rats
17. Local inflammation caused by a monoclonal antibody that blocks the function of the rat membrane inhibitor of C3 convertase
18. Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement
19. Role of a rat membrane inhibitor of complement in anti-basement membrane antibody-induced renal injury
20. Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells
21. Rosette formation of human erythrocytes on cultured cells of tumor origin and activation of complement by cell membrane
22. Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells
23. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells
24. Endotoxin-induced shock in the rat. A role for C5a
25. Role of complement in endotoxin/platelet-activating factor-induced lung injury
26. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin
27. The pathogenesis of sepsis
28. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies
29. Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion
30. Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis
31. Soluble complement receptor type 1 inhibited the systemic organ injury caused by acid instillation into a lung
32. The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis
33. Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis